- Home
- QGEN vs FDS Comparison
QGEN vs FDS Comparison
Compare QGEN & FDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QGEN | FDS |
|---|---|---|
| Founded | 1986 | 1978 |
| Country | Netherlands | United States |
| Employees | N/A | 6258 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 9.1B |
| IPO Year | 1998 | 1996 |
Fundamental Metrics
Financial Performance| Metric | QGEN | FDS |
|---|---|---|
| Price | $43.84 | $283.84 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 11 |
| Target Price | $45.76 | ★ $284.80 |
| AVG Volume (30 Days) | ★ 2.2M | 788.1K |
| Earning Date | 05-06-2026 | 03-31-2026 |
| Dividend Yield | ★ 7.17% | 1.89% |
| EPS Growth | N/A | ★ 11.79 |
| EPS | N/A | ★ 11.16 |
| Revenue | N/A | ★ $1,435,351,000.00 |
| Revenue This Year | $8.18 | $7.16 |
| Revenue Next Year | $5.71 | $5.55 |
| P/E Ratio | ★ $24.01 | $25.59 |
| Revenue Growth | N/A | ★ 6.31 |
| 52 Week Low | $32.53 | $185.00 |
| 52 Week High | $57.82 | $387.75 |
Technical Indicators
Market Signals| Indicator | QGEN | FDS |
|---|---|---|
| Relative Strength Index (RSI) | 68.74 | 62.42 |
| Support Level | $42.82 | $280.01 |
| Resistance Level | $44.03 | $300.77 |
| Average True Range (ATR) | 0.85 | 10.62 |
| MACD | 0.03 | 1.40 |
| Stochastic Oscillator | 85.92 | 78.83 |
Price Performance
Historical ComparisonAbout QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
About FDS FactSet Research Systems Inc.
FactSet provides financial data and portfolio analytics to the global investment community. The company aggregates data from third-party data suppliers, news sources, exchanges, brokerages, and contributors into its workstations. In addition, it provides essential portfolio analytics that companies use to monitor portfolios and address reporting requirements. Buy-side clients (including wealth and corporate clients) account for over 80% of FactSet's annual subscription value. In 2015, the company acquired Portware, a provider of trade execution software. In 2017, it acquired BISAM, a risk management and performance measurement provider. In 2022, it completed its purchase of CUSIP Global Services.